Methylprednisolone Acetate — manufacturers, supply & price · Pillstats

Who makes it9 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
Amneal Pharmaceuticals LLC	unknown	14	SUPPLYING
Pharmacia & Upjohn Company LLC	unknown	6	SUPPLYING
A-S Medication Solutions	unknown	4	SUPPLYING
Eugia US LLC	unknown	4	SUPPLYING
Asclemed USA, Inc.	unknown	3	SUPPLYING
Sportpharm LLC	unknown	3	SUPPLYING
Sagent Pharmaceuticals	unknown	3	SUPPLYING
Endo USA, Inc.	unknown	2	SUPPLYING
Caplin Steriles Limited	unknown	2	SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

Apr 25, 2024
RECALLRecall (Class II): MethylPREDNISolone Acetate Injectable Suspension, USP, 400 mg per 10 mL (40 mg per mL), 1 x 10 mL Multi-Dose Vial, Rx o…
Presence of Particulate Matter: Potential for black particulates in the drug product. — Recalling firm: Sagent Pharmaceuticals — Nationwide in the USA
Feb 20, 2024
RECALLRecall (Class II): Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. in…
Failed Dissolution Specifications — Recalling firm: Eugia US LLC — OH, TN, LA, MS
Jun 16, 2022
SHORTAGEDrug shortage: Methylprednisolone Acetate Injection (Par Health, USA LLC)
Methylprednisolone Acetate Injection — reported in shortage by Par Health, USA LLC. Therapeutic category: Rheumatology.
Apr 13, 2022
RECALLRecall (Class II): Depo-Medrol (methylprednisolone acetate injectable suspension, USP) 40 mg/mL, 1 mL single-dose vial, Rx only, MFG: Pfiz…
cGMP deviations: Temperature abuse — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — USA nationwide.
Apr 13, 2022
RECALLRecall (Class II): Depo-Medrol (methylprednisolone acetate injectable suspension, USP) 80mg/mL, packaged in a) 1 mL single-dose vial (NDC#…
cGMP deviations: Temperature abuse — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — USA nationwide.
Dec 15, 2021
SHORTAGEDrug shortage: Methylprednisolone Acetate Injection (Sagent Pharmaceuticals)
Methylprednisolone Acetate Injection — reported in shortage by Sagent Pharmaceuticals. Therapeutic category: Rheumatology.
Dec 15, 2021
SHORTAGEDrug shortage: Methylprednisolone Acetate Injection (Amneal Pharmaceuticals)
Methylprednisolone Acetate Injection — reported in shortage by Amneal Pharmaceuticals. Therapeutic category: Rheumatology.
Dec 15, 2021
SHORTAGEDrug shortage: Methylprednisolone Acetate Injection (Eugia US LLC)
Methylprednisolone Acetate Injection — reported in shortage by Eugia US LLC. Therapeutic category: Rheumatology.
Jul 30, 2014
RECALLRecall (Class III): Depo-Medrol (methylprednisolone acetate injectable suspension USP), 40 mg/ mL, 1 mL Single-Dose Vial, Rx only, Distribu…
Failed pH Specification: A pH result of 2.9 was obtained at the 9 month stability test interval at 25C/60%RH. The registered specification for pH is 3.0 - 7.0 — Recalling firm: Pfizer Inc. — Nationwide

Methylprednisolone Acetate

US acquisition costNADAC · per unit

Medicaid dispensing volumeSDUD · per quarter

Who makes it9 active · 0 exited

Regulatory & supply eventsFDA · US